Madison Ave. Has Growing Role In the Business of Drug Research. Dentists leafing through The Journal of the American Dental Association last May found a study concluding that a new drug called Bextra offered relief from one of their patients' worst nightmares -- the acute pain that follows dental surgery.
Federal regulators had rejected that conclusion only six months before, leaving Bextra's marketers, Pharmacia and Pfizer, hard pressed to sell it as an advance over Celebrex, their earlier entry in a crowded market for pain drugs. The new study helped light a fire under Bextra. Its sales soared 60 percent over the three months that followed, according to industry data. But the research was not conducted by academics.
Big Pharma and Madison Avenue. Dentists leafing through The Journal of the American Dental Association last May found a study concluding that a new drug called Bextra offered relief from one of their patients' worst nightmares - the acute pain that follows dental surgery.
Federal regulators had rejected that conclusion only six months before, leaving Bextra's marketers, Pharmacia and Pfizer, hard pressed to sell it as an advance over Celebrex, their earlier entry in a crowded market for pain drugs. The new study helped light a fire under Bextra. Its sales soared 60 percent over the three months that followed, according to industry data. Omnicom Group - Home. Omnicom Group. Omnicom Group Inc. is an American global advertising, marketing and corporate communications holding company, headquartered in New York City.
Interpublic Group: home. Interpublic Group of Companies. The Interpublic Group of Companies, Inc.
(IPG) is one of the big four global advertising holding companies (the others being Omnicom, WPP and Publicis). It is headquartered in New York City and is the parent company of advertising and marketing services agencies around the world. The company consists of three major networks: McCann Worldgroup, Lowe and Partners, and Draftfcb. Its media agencies are bundled under the IPG Mediabrands entity. It also owns a number of specialty agencies, including public relations, sports marketing, talent representation and healthcare.[1] Michael Roth is the current IPG Chief Executive Officer. History[edit] Advertising, Branding, Consumer Insight, Digital, Marketing, Public Relations, Design, Media.
Go Stock quote uk 1540.00 us 116.26 Last updated at: 08:24 GMT Detailed price information.
WPP plc. WPP plc is a British multinational advertising and public relations company with its main management office in London, United Kingdom, and its executive office in Dublin, Ireland.[3] It is the world's largest advertising company by revenues, and employs around 162,000 people in 3,000 offices across 110 countries.[2][4] It owns a number of advertising, public relations and market research networks, including Grey, Burson-Marsteller, Hill & Knowlton, JWT, Ogilvy Group, TNS, Young & Rubicam and Cohn & Wolfe.[2] WPP has a primary listing on the London Stock Exchange and is a constituent of the FTSE 100 Index.
It has a secondary listing on NASDAQ. History[edit] Publicis Groupe. Publicis. On 28 July 2013, it was announced that Publicis Groupe and Omnicom Group would merge to form Publicis Omnicom Group.[3] Overview[edit] The company was founded by Marcel Bleustein-Blanchet in 1926.[4] The company owned several full-service advertising groups that undertake a range of media activities: mobile and interactive online communication, television, magazines & newspapers, cinema and radio, outdoor.
The company's SAMS services include direct marketing/customer relationship management services, sales promotion, healthcare communications, multicultural and ethnic communications, corporate and financial communications, human resource infrastructure, public relations, design services, interactive communications, events marketing and management, sports marketing, and production and pre-press services.[5] Its media services include media planning, media buying, and media sales.
Publicis Groupe's Vivaki pole has developed a technological platform supported by Microsoft, Google, Yahoo! Torre Lazur. Scirex - Premier Research. The Social Study of Corporate Science: A Research Manifesto. Bart Penders Annemiek Nelis Laboratory ethnographies have provided valuable insights in the workings of contemporary science and technology and about facts in the making.
Nearly all these ethnographic studies have been conducted at nonprofit research institutes. In this article, the authors argue that it is time for science and technology studies (STS) ethnography to direct its gaze toward for-profit knowledge production sites. The authors do so, based on a long-standing recognition that nonprofit academic laboratories do not have a monopoly on knowledge construction. . © The Author(s) 2009. John Verbakel, Vice President Research and Development. Prof Accuses Colleagues of Slanted Research. By Paul Basken A University of Pennsylvania psychiatry professor has accused his department chairman and four colleagues of publishing an article that was ghostwritten on behalf of a pharmaceutical company and made unsupported claims for one of its best-selling drugs.
The medical-journal article, published in 2001, "was biased in its conclusions" and "made unsubstantiated efficacy claims and downplayed" negative side effects of the antidepressant drug Paxil, according to a complaint filed by lawyers for Jay D. Amsterdam, a professor of psychiatry at Penn. Dr. Amsterdam's complaint was filed with the Office of Research Integrity of the U.S. An article reporting the research appeared in the June 2001 issue of the American Journal of Psychiatry with eight listed authors. Jay. D. Amsterdam. Universities Get Advice on How to Avoid Ghostwriting Scandals in Research Articles - Government. By Paul Basken Universities have been struggling for years with the problem of researchers who let industry-financed ghostwriters draft biased summaries of their work for publication in medical journals.
They're now getting some blunt advice on how to stop it, including from perhaps the most qualified experts: the ghostwriters themselves. In a pair of articles published Tuesday by PLoS Medicine, two professional medical writers outlined changes that both universities and the journals could make. Being the Ghost in the Machine: A Medical Ghostwriter's Personal View. Citation: Logdberg L (2011) Being the Ghost in the Machine: A Medical Ghostwriter's Personal View. PLoS Med 8(8): e1001071. doi:10.1371/journal.pmed.1001071. Image oAqR. The Power of Rehabilitation. Columbia University in the City of New York.
Linda Logdberg - Georgia Perimeter College [all campuses] ? Linda Logdberg ? Dr Logdberg's webpage. Authorship rules for medical journals flouted by pharma industry, experts say. Rather than ensure the proper attribution of authorship, rules set up by leading medical journals to define and credit authorship of published articles are exploited by the pharmaceutical industry in its attempt to conceal and misrepresent industry contributions to the literature. How Industry Uses the ICMJE Guidelines to Manipulate Authorship—And How They Should Be Revised.
Citation: Matheson A (2011) How Industry Uses the ICMJE Guidelines to Manipulate Authorship—And How They Should Be Revised. PLoS Med 8(8): e1001072. doi:10.1371/journal.pmed.1001072 Published: August 9, 2011 Copyright: © 2011 Alastair Matheson. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Funding: The author received no specific funding, payment or grant of any kind to research or write this article. Image L2Jx. ICMJE: Uniform Requirements for Manuscripts Submitted to Biomedical Journals. Legal Remedies for Medical Ghostwriting: Imposing Fraud Liability on Guest Authors of Ghostwritten Articles. Citation: Stern S, Lemmens T (2011) Legal Remedies for Medical Ghostwriting: Imposing Fraud Liability on Guest Authors of Ghostwritten Articles. PLoS Med 8(8): e1001070. doi:10.1371/journal.pmed.1001070 Published: August 2, 2011.
Carrie Wolinetz. Dr. Wolinetz is Associate Vice President for Federal Relations with the Association of American Universities. Her primary responsibility is to coordinate advocacy on funding and policy issues relating to the National Institutes of Health and biomedical research. Carrie Wolinetz (Dr_CarrieDale) sur Twitter. Medicijn op zoek naar een ziekte. Marketeers schreven positieve artikelen over een zeer omstreden middel. Artsen zetten hun naam erboven. Trouw: Wetenschappelijke fraude komt vaker voor.
Harvard Medical School Professor Among Five Accused of Ghostwriting. Updated July 13, 11:55 a.m. | A complaint filed with the federal Office of Research Integrity alleged that a group of psychiatrists, including an associate professor at the Harvard Medical School, signed their names to an academic paper written by a communications firm hired by a major pharmaceutical company. Gary S. Sachs, a researcher affiliated with Massachusetts General Hospital, is one of five doctors identified in the formal accusation filed July 8 by University of Pennsylvania professor Jay D. Amsterdam. BMJ: Honorary and ghost authorship in high impact biomedical journals: a cross sectional survey.
NTvG: Onrechtmatig auteurschap nog steeds grootschalig probleem. Onrechtmatig auteurschap op wetenschappelijke artikelen is nog steeds schering en inslag. Bij meer dan een vijfde van de artikelen in 6 hoog aangeschreven medische tijdschriften is ofwel sprake van ghostwriterschap of er staat een naam boven het artikel van iemand die niet of nauwelijks heeft bijgedragen aan het manuscript (ere-auteurschap).